1. Department of Internal Medicine 3, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany;
2. Clinical Cooperative Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany;
3. German Cancer Consortium (DKTK), Heidelberg, Germany;
4. German Cancer Research Center (DKFZ), Heidelberg, Germany;
5. Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany;
6. Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany;
7. Center for Human Genetics, Philipps University, Marburg, Germany;
8. Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, Ludwig-Maximilians-Universität, Munich, Germany;
9. Institute of Biostatistics and Clinical Research, and
10. Department of Medicine A - Hematology, Oncology and Pneumology, University of Münster, Münster, Germany;
11. German Society of Hematology and Oncology, Berlin, Germany; and
12. Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand